News | April 22, 2026
Zyax Chem takes 26% stake in Gaymed Labs
Targets high-growth eye care expansion push
Targets high-growth eye care expansion push
Manoj has over two decades of experience in healthcare operations and biomedical engineering
The newly approved pill combines 100 mg of doravirine with 0.25 mg of islatravir
The deal the group says marks a decisive push deeper into severe infectious diseases and the build-out of a global specialty pharmaceuticals platform
By cutting pain crises & boosting haemoglobin
Policy symposium in Hyderabad focuses on life skills education and community?driven solutions
The plant is currently scaling towards a production capacity of nearly 3 million gloves per day
The company announced that its Phase III FENhance 1 and 2 studies both met their primary endpoints
The Phase III METEOROID study met its primary endpoint, with ENSPRYNG cutting the risk of a first relapse by 68% compared to placebo in adults and adolescents
The approval, following a positive recommendation from the European Medicines Agency’s CHMP, makes the vaccine valid across all 27 EU member states
Subscribe To Our Newsletter & Stay Updated
